PEN Q1 2023 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$241M+18.4% YoY

Gross Profit

$151M62.6% margin

Operating Income

$8M3.3% margin

Net Income

$9M3.5% margin

EPS (Diluted)

$0.22

QoQ Revenue Growth

+9.1%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$9M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$371M

Stockholders' Equity

$1.0B

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$241M	$204M	+18.4%
Gross Profit	$151M	$127M	+18.6%
Operating Income	$8M	-$4M	+297.9%
Net Income	$9M	$79,000	+10738.0%

Revenue Segments

Peripheral Vascular

$143M59%

Neuro

$99M41%

Geographic Segments

UNITED STATES

$172M71%

Other Non-US

$70M29%